Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
United Laboratories International Holdings OCF Margin % Chart
United Laboratories International Holdings Annual Data
For the Drug Manufacturers - Specialty & Generic subindustry, United Laboratories International Holdings's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
United Laboratories International Holdings OCF Margin % vs Drug Manufacturers Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
United Laboratories International Holdings (FRA:UNJ) has a OCF Margin % of 30.79% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on United Laboratories International Holdings and its competitors. This is 73% above median its historical median of 17.81. Over the past decade, United Laboratories International Holdings' OCF Margin % has ranged from 11.28 to 28.38. According to the industry distribution chart, United Laboratories International Holdings ranks #83 out of 964 companies in the Drug Manufacturers industry, placing it in the top 8.6%.
Is United Laboratories International Holdings' OCF Margin % too high?
United Laboratories International Holdings' current OCF Margin % of 30.79% is 73% above median its 10-year median of 17.81. Over the past 10 years, this metric has ranged from a low of 11.28 to a high of 28.38. The Drug Manufacturers industry median OCF Margin % is 10.04. United Laboratories International Holdings' value of 30.79% is 206.8% above this industry median. Based on the distribution chart, United Laboratories International Holdings ranks #83 out of 964 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, United Laboratories International Holdings has a GF Score™ of 90/100, reflecting its overall financial health beyond just this single metric.
How does United Laboratories International Holdings' OCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, United Laboratories International Holdings ranks #83 out of 964 companies for OCF Margin %. This places United Laboratories International Holdings in the top 9% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 10.04. United Laboratories International Holdings' value of 30.79% is 206.8% above this benchmark. Historically, United Laboratories International Holdings' own OCF Margin % has ranged from 11.28 to 28.38 over the past decade. While the company's 10-year median is 17.81 vs. the industry median of 10.04, United Laboratories International Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 10.04, based on 964 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. United Laboratories International Holdings's current OCF Margin % of 30.79% is 206.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on United Laboratories International Holdings and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 10.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. United Laboratories International Holdings's current OCF Margin % is 30.79%, which is 73% above median its own 10-year median of 17.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is United Laboratories International Holdings stock overvalued right now?
United Laboratories International Holdings (FRA:UNJ) has a current OCF Margin % of 30.79%. The stock's GF Value™ is €0.96, compared to a current price of €1.00 — trading 4.2% above its estimated fair value. The current OCF Margin % is 30.79%, which is 73% above median its 10-year median of 17.81 and 206.8% above the Drug Manufacturers industry median of 10.04. United Laboratories International Holdings' overall GF Score™ is 90/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For United Laboratories International Holdings (FRA:UNJ), the current OCF Margin % is 30.79% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is United Laboratories International Holdings (FRA:UNJ) Overvalued in 2026?
Based on GuruFocus' analysis, United Laboratories International Holdings stock appears to be overvalued.
The current stock price of €1.00 is trading 4.2% above its estimated GF Value™ of €0.96.
Key valuation signals for FRA:UNJ:
OCF Margin %: 30.79% (73% above median its 10-year median of 17.81)
GF Value™: €0.96 vs. price of €1.00 (4.2% above fair value)
Industry Position: 206.8% above the Drug Manufacturers median (#83 of 964)
No single metric tells the full story. See the FRA:UNJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
United Laboratories International Holdings Business Description
United Laboratories International Holdings Ltd is mainly engaged in the research and development, production and sales of pharmaceuticals. The company operates in three segments: Intermediate products, Bulk medicine, and Finished products. The company's Finished products segment includes antibiotic products, insulin series products, and other medicines. The vast majority of the company's revenue is derived from its Finished products segment, followed by Bulk medicine. The majority of the company's sales are generated in China, followed by Europe, India and other countries.
90GF Score
Get the complete analysis for FRA:UNJ
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:UNJ has been successfully added to your 
